Short- and long-term results after prosthetic mitral valve implantation in patients with severe mitral annulus

Ronny Ben-Avi1, Boris Orlov1, Leonid Sternik1

  • 1Department of Cardiac Surgery, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Affiliated to the Sackler School of Medicine, Tel Aviv University, Israel.

Abstract

Insights

A conservative approach to mitral annulus calcification (MAC) in mitral valve replacement (MVR) surgery shows comparable short- and long-term outcomes to MVR without MAC. This method is suitable for most patients undergoing MVR with MAC.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Surgery
  • Mitral Valve Replacement

Background:

  • Mitral annulus calcification (MAC) presents challenges during mitral valve replacement (MVR) surgery.
  • A conservative decalcification approach is one strategy to manage MAC.

Purpose of the Study:

  • To investigate the short- and long-term clinical and echocardiographic outcomes of a conservative decalcification approach in MVR surgery for patients with MAC.
  • To compare these outcomes with MVR patients without MAC.

Main Methods:

  • A propensity score-matched analysis compared 133 MVR patients with significant MAC undergoing conservative decalcification to 118 MVR patients without MAC.
  • The conservative approach involved decalcification, supra-annular prosthesis implantation, and a pericardial patch.

Main Results:

  • Early mortality was similar (5%) between groups. Late mortality at 6 years was 33% in the MAC group and 29% in the non-MAC group (P=0.55).
  • Functional class, freedom from moderate/severe mitral regurgitation, and mean transvalvular gradient did not significantly differ between groups at follow-up.
  • No significant differences were observed in early or late paravalvular leak rates.

Conclusions:

  • A conservative decalcification strategy is effective and suitable for the majority of patients with MAC undergoing MVR.
  • This approach yields comparable early and late clinical and echocardiographic outcomes to MVR in patients without MAC.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
390
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
469
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
986
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
888
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
371
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
791